Cypris Achieves SOC 2 Type II Compliance

January 15, 2025
# min read
soc 2 compliance badge

Cypris Achieves SOC 2 Type II Compliance, Setting a New Standard for Data Security in Innovation Management

New York, NY – Cypris is proud to announce that it has achieved SOC 2 Type II compliance in accordance with the American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations, also known as SSAE 18. Achieving this milestone with an unqualified opinion serves as third-party validation of Cypris’ commitment to providing enterprise-level security for customer data within its AI-powered R&D platform.

In today's fast-paced innovation landscape, safeguarding sensitive data is paramount. Cypris’ SOC 2 Type II compliance reflects its dedication to maintaining the highest standards in data security, privacy, and operational integrity. This rigorous certification evaluates an organization’s systems and the effectiveness of its controls over time, ensuring they are robust and reliable enough to manage customer data securely and responsibly.

With this achievement, Cypris continues to solidify its role as a trusted partner for R&D and innovation leaders, offering secure, actionable insights to accelerate breakthroughs.

About Cypris:

Cypris is a market intelligence platform built for research and development and innovation teams. Designed to serve as a single ecosystem for global innovation data, the Cypris platform and its custom research services allow users to gain unique insights from over 500 million data points. This enables them to answer key questions about their market, competitors, and core technologies, supporting new product development, commercial strategy, and accelerating global innovation. To learn more about Cypris and how they help R&D and innovation teams, visit cypris.ai.

Similar insights you might enjoy

Best Prior Art Search Software for 2026: AI Tools and Enterprise Platforms Compared

Prior art search software in 2026 ranges from legacy patent platforms to free tools to modern enterprise R&D intelligence systems. Cypris represents the current state of the art for enterprise teams, combining a proprietary R&D ontology with unified access to 500+ million patents and scientific publications and AI-powered synthesis trusted by Fortune 100 companies including Johnson & Johnson, Honda, and Yamaha. Legacy platforms like Orbit Intelligence and Derwent Innovation continue serving patent professionals who value traditional Boolean search precision and established workflows, though their patent-centric architectures and older interfaces limit applicability for broader technology research. Free tools including Google Patents, Espacenet, USPTO Patent Public Search, and PQAI provide accessible starting points for preliminary research but lack the data coverage, AI sophistication, and enterprise capabilities required for comprehensive prior art analysis. Organizations should evaluate platforms based on data breadth across patents and non-patent literature, AI architecture and whether platforms employ domain-specific ontologies, integration with R&D workflows, and alignment with whether users are patent professionals or corporate research teams.

Best Prior Art Search Software for 2026: AI Tools and Enterprise Platforms Compared

Prior art search software in 2026 ranges from legacy patent platforms to free tools to modern enterprise R&D intelligence systems. Cypris represents the current state of the art for enterprise teams, combining a proprietary R&D ontology with unified access to 500+ million patents and scientific publications and AI-powered synthesis trusted by Fortune 100 companies including Johnson & Johnson, Honda, and Yamaha. Legacy platforms like Orbit Intelligence and Derwent Innovation continue serving patent professionals who value traditional Boolean search precision and established workflows, though their patent-centric architectures and older interfaces limit applicability for broader technology research. Free tools including Google Patents, Espacenet, USPTO Patent Public Search, and PQAI provide accessible starting points for preliminary research but lack the data coverage, AI sophistication, and enterprise capabilities required for comprehensive prior art analysis. Organizations should evaluate platforms based on data breadth across patents and non-patent literature, AI architecture and whether platforms employ domain-specific ontologies, integration with R&D workflows, and alignment with whether users are patent professionals or corporate research teams.

Academic Partnership Opportunities in mRNA Innovation in North America & Europe

This Cypris Q report identifies fifteen high-priority academic partners across North America and Europe for mRNA technology collaboration, evaluating institutions based on peer-reviewed publications, patent activity, and commercialization readiness. Three strategic partnership categories emerge as critical: delivery and targeting platforms offering the highest strategic leverage, stability and lyophilization science providing near-term manufacturing ROI, and next-generation modalities including saRNA and circRNA delivering pipeline differentiation. Top-tier targets include University of British Columbia, Ghent University, Imperial College London, University of Pennsylvania, and Cornell University, each offering distinct capabilities spanning LNP optimization, cold-chain relief, and translational IP with demonstrated collaboration maturity.

Academic Partnership Opportunities in mRNA Innovation in North America & Europe

This Cypris Q report identifies fifteen high-priority academic partners across North America and Europe for mRNA technology collaboration, evaluating institutions based on peer-reviewed publications, patent activity, and commercialization readiness. Three strategic partnership categories emerge as critical: delivery and targeting platforms offering the highest strategic leverage, stability and lyophilization science providing near-term manufacturing ROI, and next-generation modalities including saRNA and circRNA delivering pipeline differentiation. Top-tier targets include University of British Columbia, Ghent University, Imperial College London, University of Pennsylvania, and Cornell University, each offering distinct capabilities spanning LNP optimization, cold-chain relief, and translational IP with demonstrated collaboration maturity.